RxDoctor Payments Data

Stephanie Lindstrom, MD

Family Medicine · Metamora, ILNPI 1811903073

Payments from drug & device makers

$645in general payments, 2019–2025

Across 26 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$222
  • Boston Scientific$137
  • Amgen$65
  • Boehringer Ingelheim$44
  • Lilly USA, LLC$25
  • Avanir Pharmaceuticals, Inc.$21
  • plus $131 from 8 others

What the payments were for

  • Food & beverage$645100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$645 in reported general payments places this provider in the 65th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$74,751
Medicare patients
208
Services billed
2,285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide64$92,720
EliquisApixaban20$25,829
XareltoRivaroxaban20$19,030
JardianceEmpagliflozin11$15,785
MounjaroTirzepatide12$11,586
Incruse ElliptaUmeclidinium Bromide12$5,961
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$5,869
Pantoprazole Sodium37$2,895
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$2,004
Sertraline Hcl58$1,834
Levothyroxine Sodium236$1,772
Scopolamine14$1,712
Albuterol Sulfate HfaAlbuterol Sulfate29$1,485
Metoprolol Succinate76$1,294
Atorvastatin Calcium197$1,223

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$11$25,82920 claims
Boehringer IngelheimJardiance$44$15,78511 claims
Lilly USA, LLCMounjaro, Olanzapine$25$12,08523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Metamora

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →